Time to Close the Gap Between Guidelines and the Reimbursement Policy for Diabetes Treatment in Turkey Alper Tuna Güven Commentary 06 June 2023 Pages: 843 - 844
How Much Better is Faster? Value Adjustments for Health-Improvement Sequences F. Reed JohnsonJuan Marcos GonzalezShelby D. Reed Leading Article 03 May 2023 Pages: 845 - 856
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Willem WitloxSabine GrimmManuela Joore Review Article Open access 02 May 2023 Pages: 857 - 867
Cost-Effectiveness of Thrombopoietin Mimetics in Patients with Thrombocytopenia: A Systematic Review Hans Van RemoortelHans ScheersPhilippe Vandekerckhove Systematic Review 05 May 2023 Pages: 869 - 911
Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review Charles OkaforJoshua ByrnesClifford Afoakwah Systematic Review Open access 19 May 2023 Pages: 913 - 943
A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Lara ChayabNatalia KonstantelosWilliam W. L. Wong Systematic Review 03 June 2023 Pages: 945 - 980
Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer Marianne LuyendijkAgnes JagerHedwig M. Blommestein Original Research Article Open access 28 May 2023 Pages: 981 - 997
Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study) Maria Jesus Rodríguez-NietoEsteban Cano-JiménezSilvia Armengol Original Research Article Open access 30 May 2023 Pages: 999 - 1010
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers Aurelie MeunierLouise LongworthSanjay Popat Original Research Article 09 June 2023 Pages: 1011 - 1025